1 month agoProgress, Potential, and Possibilities Weekly Re-Broadcast - 4/13/25ProgressPotentialAndPossibilities
1 month agoDr. Peter Ordentlich, Ph.D. - CSO & Founder, Syndax Pharmaceuticals - Reimagining Cancer TreatmentProgressPotentialAndPossibilities
